United States

Jiangsu Hengrui Medicine Co Ltd (600276.SS)

600276.SS on Shanghai Stock Exchange

2:59am EDT
Change (% chg)

¥-0.34 (-0.73%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 600276.SS


JIANGSU HENGRUI MEDICINE CO., LTD. is principally engaged in the manufacturing and distribution of pharmaceutical tablets, injections and raw materials. The Company’s main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, drugs for the treatment of endocrine, antibiotics, infusions... (more)


Beta: 0.45
Market Cap(Mil.): ¥109,371.30
Shares Outstanding(Mil.): 2,347.53
Dividend: 0.08
Yield (%): 0.18


  600276.SS Industry Sector
P/E (TTM): 42.84 33.54 33.70
EPS (TTM): 1.09 -- --
ROI: 24.39 14.51 13.98
ROE: 24.31 15.28 14.91

BRIEF-Jiangsu Hengrui Medicine's H1 net profit up 24 pct y/y

* Says H1 net profit up 23.85 percent y/y at 1.3 billion yuan ($194.66 million)

Aug 29 2016

BRIEF-Jiangsu Hengrui Medicine and unit receive approval for drug clinic trial

* Says the co and unit get China Food and Drug Administration's approval for its SHR-1314 injection which will be mainly used for the treatment of psoriasis

Jul 05 2016

BRIEF-Linhai to acquire Jiangsu linhai power machinery group for 448.4 mln yuan via share issue and funds raising

* Says it plans to acquire 100 percent stake in Jiangsu linhai power machinery group Co. from China Fuma Group Co., Ltd via share issue

Jun 15 2016

Earnings vs. Estimates